All In Biotech

Drug Trial Radar · NCT06516042

Targeted Antimalarial Drug Administration for Seasonal Migrant Populations in Amhara Region, Ethiopia

Effectiveness, Feasibility, and Acceptability of Targeted Antimalarial Interventions for Seasonal Migrant Populations in Metema District, Amhara Region, Ethiopia

Last checked: Nov 20, 2026Latest source record: May 6, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 10,350 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

10,350

Planned (sponsor's estimate)

Start

Aug 21, 2024

Primary completion

Jan 24, 2025

Study completion Jul 2025

Sponsor

Lead sponsor
PATHAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Federal Minstry of Health of Ethiopia
First posted
Jul 23, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Prevention
FDA-regulated drug
No
Who can join
All sexes, from 14 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of the study is to assess the effectiveness, feasibility, and acceptability of targeted drug administration for seasonal migrant populations in Metema District, Amhara Region, Ethiopia

Conditions

  • Plasmodium Falciparum
  • Malaria

Interventions

  • Dihydroartemisinin-piperaquineDrug

    Participants that provide consent to participate in the TDA and are deemed eligible for treatment will receive a course of dihydroartemisinin-piperaquine (DP) if male, and artemether-lumefantrine (AL) if female. They will take the first dose of the treatment under direct observed therapy, and will receive the rest of the tablets to take on their own for days two and three.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Plasmodium falciparum (Pf) parasite prevalenceTime frame: Up to 6 months
  2. Feasibility of TDATime frame: Up to 6 months
  3. Acceptability of TDA amongst farmworkers, farm-site owners, and local health authoritiesTime frame: Up to 6 months

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Delello Farm Sites

    Gonder, Metema District, Ethiopia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.